We are live on ! Find out more
FMS icon

Fresenius Medical Care

197 hedge funds and large institutions have $370M invested in Fresenius Medical Care in 2018 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 44 increasing their positions, 67 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.18% less ownership

Funds ownership: 4.89%3.71% (-1.2%)

12% less funds holding

Funds holding: 223197 (-26)

34% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 67

36% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 69

52% less capital invested

Capital invested by funds: $772M → $370M (-$402M)

Holders
197
Holders Change
-26
Holders Change %
-11.66%
% of All Funds
4.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
44
Increased
44
Reduced
67
Closed
69
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$48.2M +$15.8M +390,902 +36%
Northern Trust
2
Northern Trust
Illinois
$25.5M -$2.85M -70,547 -8%
TIM
3
Thornburg Investment Management
New Mexico
$21.7M +$7.63M +188,973 +39%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$20.4M -$1.53M -37,875 -6%
Bank of America
5
Bank of America
North Carolina
$18.3M -$4.12M -101,980 -15%
Arrowstreet Capital
6
Arrowstreet Capital
Massachusetts
$11.8M -$2.07M -51,246 -12%
PPA
7
Parametric Portfolio Associates
Washington
$11.2M -$8.65M -214,198 -38%
Deutsche Bank
8
Deutsche Bank
Germany
$10.7M +$12.6M +311,750 +1,659%
OMC
9
Old Mission Capital
Illinois
$10.3M +$12.3M +303,642 +2,190%
JFL
10
Jarislowsky, Fraser Ltd
Quebec, Canada
$9.39M -$328K -8,130 -3%
RG
11
Renaissance Group
Kentucky
$9.17M -$2.2M -54,585 -16%
US Bancorp
12
US Bancorp
Minnesota
$8.98M -$563K -13,936 -5%
Renaissance Technologies
13
Renaissance Technologies
New York
$8.08M +$9.38M +232,300 +1,358%
Millennium Management
14
Millennium Management
New York
$7.6M +$9.47M +234,680 New
Two Sigma Investments
15
Two Sigma Investments
New York
$7.55M +$9.41M +233,189 New
Goldman Sachs
16
Goldman Sachs
New York
$7.32M +$2.02M +50,109 +29%
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$6.86M +$7.28M +180,445 +576%
Envestnet Asset Management
18
Envestnet Asset Management
Illinois
$6.86M +$8.27M +204,800 +3,000%
State Farm Mutual Automobile Insurance
19
State Farm Mutual Automobile Insurance
Illinois
$6.83M +$1.23M +30,426 +17%
HL
20
Harding Loevner
New Jersey
$6.53M -$161M -3,996,267 -95%
AG
21
Aperio Group
California
$6.28M -$1.91M -47,312 -20%
Jane Street
22
Jane Street
New York
$5.86M +$5.77M +142,867 +375%
Wells Fargo
23
Wells Fargo
California
$5.83M -$3.74M -92,648 -34%
Franklin Resources
24
Franklin Resources
California
$5.83M +$418K +10,352 +6%
BNP Paribas Asset Management
25
BNP Paribas Asset Management
France
$5.83M +$7.31M +181,019 New

FMS Hedge Fund Activity: Q4 2018 in Review

197 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q4 2018, worth a combined $370M — down 52% from $772M a quarter earlier.

Sellers outnumbered buyers: 69 funds closed out of FMS and 44 opened new positions — a net loss of 25 holders — while 67 trimmed existing stakes and 44 added.

The largest buyer was Morgan Stanley, adding an estimated $15.8M. The largest seller was Harding Loevner, cutting an estimated $161M.

  • 197 institutional investors held Fresenius Medical Care (FMS) as of Q4 2018, down from 223 in Q3 2018.
  • Funds reported $370M of Fresenius Medical Care stock for Q4 2018, down 52% quarter-over-quarter.
  • 44 funds opened new Fresenius Medical Care positions in Q4 2018 and 69 closed out, a net change of -25 holders.
  • The largest Fresenius Medical Care buyer in Q4 2018 was Morgan Stanley, an estimated $15.8M added.
  • The largest Fresenius Medical Care seller in Q4 2018 was Harding Loevner, an estimated $161M sold.

Based on aggregated 13F filings for Q4 2018.